Invitation to Nanoform’s Q2 2024 Report Presentation
Press release Nanoform Finland Plc August 16, 2024 11:00 a.m.…
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
Press release Nanoform Finland Plc August 15, 2024 08:10 a.m.…
Nanoform Finland Plc – Manager’s Transactions – Miguel Calado
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Mads Laustsen
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Jeanne Thoma
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Share subscriptions based on the resolution by Nanoform Finland Plc’s Annual General Meeting 2024 on remuneration of the Board of Directors
Company release Nanoform Finland Plc June 14, 2024 17:00 Finnish…
Nanoform’s biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned
Company Announcement Nanoform Finland Plc May 30, 2024 08:10 a.m.…